PROphet
®
PROphet
®
Technology
PROphet
TM
NSCLC Test
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical studies
Collaborators
About Us
News
In the news
Thought Leadership
Press releases
Meetings & Events
Awards
Contact Us
Careers
US openings
Israel openings
Order a test
PROphet
®
PROphet
®
Technology
PROphet
TM
NSCLC Test
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical Studies
Collaborators
News
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
Company
About us
Careers
Contact us
Order a test
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
September 20, 2021
OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response
Original source
here.
Recent news
April 10, 2024
AI tool helps doctors pick optimum cancer treatment for patients
Read more
March 29, 2024
Observational study demonstrates clinical validity and utility of OncoHost’s PROphet NSCLC test
Read more
March 22, 2024
Study in JCO® Precision Oncology Validates Clinical Efficacy of OncoHost’s PROphet® NSCLC Test
Read more
March 21, 2024
OncoHost Wins AI Excellence Award
Read more
March 21, 2024
Study Demonstrates Clinical Validity of OncoHost’s NSCLC Test
Read more
February 26, 2024
Predicting immunotherapy success via biomarkers
Read more
Read all news
